NO921829L - Nytt polypeptid, samt anti-hiv-medikament fremstilt derav - Google Patents

Nytt polypeptid, samt anti-hiv-medikament fremstilt derav

Info

Publication number
NO921829L
NO921829L NO92921829A NO921829A NO921829L NO 921829 L NO921829 L NO 921829L NO 92921829 A NO92921829 A NO 92921829A NO 921829 A NO921829 A NO 921829A NO 921829 L NO921829 L NO 921829L
Authority
NO
Norway
Prior art keywords
arg
resin
cys
dmbha
polypeptide
Prior art date
Application number
NO92921829A
Other languages
English (en)
Norwegian (no)
Other versions
NO921829D0 (no
Inventor
Nobutaka Fujii
Naoki Yamamoto
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of NO921829D0 publication Critical patent/NO921829D0/no
Publication of NO921829L publication Critical patent/NO921829L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92921829A 1990-09-11 1992-05-08 Nytt polypeptid, samt anti-hiv-medikament fremstilt derav NO921829L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23892290 1990-09-11
PCT/JP1991/001201 WO1992004374A1 (fr) 1990-09-11 1991-09-10 Nouveau polypeptide et medicament anti-vih prepare a partir de ce polypeptide

Publications (2)

Publication Number Publication Date
NO921829D0 NO921829D0 (no) 1992-05-08
NO921829L true NO921829L (no) 1992-07-09

Family

ID=17037269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921829A NO921829L (no) 1990-09-11 1992-05-08 Nytt polypeptid, samt anti-hiv-medikament fremstilt derav

Country Status (21)

Country Link
US (1) US5571892A (de)
EP (1) EP0502198B1 (de)
JP (1) JP3178835B2 (de)
KR (1) KR0184604B1 (de)
AT (1) ATE132163T1 (de)
AU (1) AU638606B2 (de)
BG (1) BG60621B1 (de)
BR (1) BR9105902A (de)
CA (1) CA2068327C (de)
CZ (1) CZ280870B6 (de)
DE (1) DE69115878T2 (de)
DK (1) DK0502198T3 (de)
ES (1) ES2081491T3 (de)
FI (1) FI922044L (de)
GR (1) GR3018879T3 (de)
HU (1) HUT61579A (de)
NO (1) NO921829L (de)
OA (1) OA10030A (de)
RO (1) RO109653B1 (de)
RU (1) RU2073685C1 (de)
WO (1) WO1992004374A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3266311B2 (ja) * 1991-05-02 2002-03-18 生化学工業株式会社 新規ポリペプチドおよびこれを用いる抗hiv剤
JP3361830B2 (ja) * 1992-03-30 2003-01-07 生化学工業株式会社 抗菌性組成物及びそれを有効成分とする薬剤
SI9420017B (sl) * 1993-03-31 2003-12-31 Merck & Co. Inc. Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a
ATE177114T1 (de) * 1993-10-14 1999-03-15 Seikagaku Kogyo Co Ltd Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
WO1998016555A1 (en) * 1996-10-15 1998-04-23 Seikagaku Corporation Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide
WO1998043995A1 (en) * 1997-03-28 1998-10-08 Seikagaku Corporation Novel anti-hiv complexes and medicinal compositions
KR20020019126A (ko) * 1999-08-09 2002-03-09 트리펩 아베 트리펩티드를 함유하는 약학 조성물
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
EP1603546A1 (de) * 2003-02-21 2005-12-14 Tripep AB Glycinamid-derivat zur hemmung der hiv-replikation
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
USD807457S1 (en) 2016-07-20 2018-01-09 Razor Usa Llc Two wheeled board
USD840872S1 (en) 2016-07-20 2019-02-19 Razor Usa Llc Two wheeled board
USD837323S1 (en) 2018-01-03 2019-01-01 Razor Usa Llc Two wheeled board
USD941948S1 (en) 2016-07-20 2022-01-25 Razor Usa Llc Two wheeled board
USD803963S1 (en) 2016-07-20 2017-11-28 Razor Usa Llc Two wheeled board
US12227257B2 (en) 2017-04-01 2025-02-18 Razor Usa Llc Electric balance vehicles
EP3728009A4 (de) 2017-12-22 2021-09-29 Razor USA LLC Elektrische gleichgewichtsfahrzeuge

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
JP2641744B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2641742B2 (ja) * 1988-08-18 1997-08-20 マルハ株式会社 新規ペプチド及び抗菌剤
JP2798711B2 (ja) * 1988-09-26 1998-09-17 生化学工業株式会社 ポリペプチド系抗ウィルス剤
JP3266311B2 (ja) * 1991-05-02 2002-03-18 生化学工業株式会社 新規ポリペプチドおよびこれを用いる抗hiv剤
JP2500194B2 (ja) 1993-08-10 1996-05-29 株式会社ヴァンドームヤマダ 商品発注システム

Also Published As

Publication number Publication date
DE69115878D1 (de) 1996-02-08
KR0184604B1 (ko) 1999-05-01
CA2068327C (en) 2002-01-01
OA10030A (en) 1996-10-14
BG60621B1 (bg) 1995-10-31
JP3178835B2 (ja) 2001-06-25
EP0502198B1 (de) 1995-12-27
AU638606B2 (en) 1993-07-01
DK0502198T3 (da) 1996-01-29
FI922044A7 (fi) 1992-05-06
RO109653B1 (ro) 1995-04-28
HUT61579A (en) 1993-01-28
HU9201540D0 (en) 1992-08-28
EP0502198A4 (en) 1993-05-05
ATE132163T1 (de) 1996-01-15
GR3018879T3 (en) 1996-05-31
DE69115878T2 (de) 1996-06-05
ES2081491T3 (es) 1996-03-16
US5571892A (en) 1996-11-05
FI922044A0 (fi) 1992-05-06
BG96323A (bg) 1993-12-24
NO921829D0 (no) 1992-05-08
CZ280870B6 (cs) 1996-04-17
WO1992004374A1 (fr) 1992-03-19
AU8448091A (en) 1992-03-30
CS139492A3 (en) 1992-09-16
CA2068327A1 (en) 1992-03-12
EP0502198A1 (de) 1992-09-09
RU2073685C1 (ru) 1997-02-20
FI922044L (fi) 1992-05-06
BR9105902A (pt) 1994-06-28

Similar Documents

Publication Publication Date Title
NO921829L (no) Nytt polypeptid, samt anti-hiv-medikament fremstilt derav
NO923142L (no) Cykliske peptider og anvendelse derav
DK126389D0 (da) Peptidforbindelser
EP0786458A3 (de) Derivate und analoge der 2-Deoxy-2,3-didehydro-N-acetyl-Neuraminsäure und ihre Verwendung als antivirale Agentien
EP0301570A3 (de) Oligopeptide, brauchbar zur Behandlung von AIDS
KR960034219A (ko) 글루카곤-유사형 인슐린 분비 촉진 착체, 조성물 및 방법
LU91166I2 (fr) Enfuvirtide, facultativement sous forme d'un sel ou ester pharmaceutiquement acceptable (FUZEON).
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
NO177716C (no) Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
DE3785066D1 (de) Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herz-kreislauf-insuffizienzen.
CA2198010A1 (en) 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
CA2399676A1 (en) Pharmacologically active antiviral peptides and methods of their use
CA2196308A1 (en) Peptide, bronchodilator and blood flow ameliorant
EP0317645A4 (de) 4h-3,1-benzoxazin-4-on-verbindungen und serin protease-inhibierende arzneimittel.
KR900001697A (ko) 치료용 화합물
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
CA2057612A1 (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
NZ256246A (en) Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
RU93005218A (ru) Полипептид, нуклеотидная последовательность, вектор, клетка, композиция, применение полипептида, способ получения полипептида
CA2078000A1 (en) Neutrophil stimulating peptides
WO1994004565A3 (en) Ipnv vaccine
SE9003040D0 (sv) Analogues of cyclolinopeptide a and the use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application